HomeCompareFRES vs VIG

FRES vs VIG: Dividend Comparison 2026

FRES yields 235.29% · VIG yields 1.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRES wins by $315.58M in total portfolio value
10 years
FRES
FRES
● Live price
235.29%
Share price
$0.85
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$315.61M
Annual income
$171,899,209.13
Full FRES calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.64%
Share price
$210.70
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.4K
Annual income
$179.15
Full VIG calculator →

Portfolio growth — FRES vs VIG

📍 FRES pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRESVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRES + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRES pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRES
Annual income on $10K today (after 15% tax)
$20,000.00/yr
After 10yr DRIP, annual income (after tax)
$146,114,327.76/yr
VIG
Annual income on $10K today (after 15% tax)
$139.33/yr
After 10yr DRIP, annual income (after tax)
$152.28/yr
At 15% tax rate, FRES beats the other by $146,114,175.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRES + VIG for your $10,000?

FRES: 50%VIG: 50%
100% VIG50/50100% FRES
Portfolio after 10yr
$157.82M
Annual income
$85,949,694.15/yr
Blended yield
54.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FRES right now

FRES
Analyst Ratings
1
Buy
Consensus: Buy
VIG
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRES buys
0
VIG buys
0
No recent congressional trades found for FRES or VIG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRESVIG
Forward yield235.29%1.64%
Annual dividend / share$2.00$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$315.61M$32.4K
Annual income after 10y$171,899,209.13$179.15
Total dividends collected$299.93M$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: FRES vs VIG ($10,000, DRIP)

YearFRES PortfolioFRES Income/yrVIG PortfolioVIG Income/yrGap
1← crossover$34,229$23,529.41$11,304$163.92+$22.9KFRES
2$111,896$75,270.83$12,759$166.33+$99.1KFRES
3$349,693$229,963.68$14,382$168.52+$335.3KFRES
4$1,045,826$671,655.14$16,192$170.52+$1.03MFRES
5$2,996,342$1,877,308.05$18,210$172.34+$2.98MFRES
6$8,232,794$5,026,707.34$20,460$173.98+$8.21MFRES
7$21,716,990$12,907,901.09$22,968$175.48+$21.69MFRES
8$55,058,944$31,821,764.79$25,763$176.83+$55.03MFRES
9$134,312,616$75,399,545.57$28,878$178.05+$134.28MFRES
10$315,613,708$171,899,209.13$32,350$179.15+$315.58MFRES

FRES vs VIG: Complete Analysis 2026

FRESStock

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Full FRES Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this FRES vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRES vs SCHDFRES vs JEPIFRES vs OFRES vs KOFRES vs MAINFRES vs DGROFRES vs NOBLFRES vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.